| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $647.7M | +12.4% |
| Cost of Revenue | $148.5M | +9.7% |
| Gross Profit | $499.2M | +13.2% |
| R&D Expense | $157.2M | +20.5% |
| SG&A Expense | $74.3M | +10.2% |
| Operating Income | $238.8M | +10.0% |
| Pre-tax Income | $272.1M | +11.0% |
| Income Tax | $50.0M | +18.7% |
| Net Income | $222.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.0M | +7.6% |
| Short-term Investments | $393.7M | -6.7% |
| Accounts Receivable | $113.6M | -18.7% |
| Inventory | $182.9M | +4.1% |
| Current Assets | $899.8M | -1.9% |
| Total Assets | $1.83B | +9.8% |
| Current Liabilities | $125.4M | +5.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $253.7M | +63.9% |
| Capital Expenditures | $42.6M | -28.7% |
| Investing Cash Flow | -$164.4M | -97.4% |
| Financing Cash Flow | -$82.3M | -12.9% |
| Free Cash Flow | $211.1M | +122.2% |
| +9.4% |
| EPS (Basic) | $4.66 | +9.6% |
| EPS (Diluted) | $4.65 | +9.7% |
| Total Liabilities |
| $215.8M |
| -2.7% |
| Stockholders' Equity | $1.62B | +11.7% |